Back To Top

Canadian Nuclear Research Initiative: Health (CNRI-H)

Canadian Nuclear Research Initiative: Health (CNRI-H)

Canadian Nuclear Laboratories’ (CNL) Canadian Nuclear Research Initiative-Health Program (CNRI-H) is a program developed by CNL to further the realization of its mission of contributing to the health of Canadians. Through CNRI-H, CNL provides financial support1 along with its expertise, experience, capabilities and makes this available and accessible to the healthcare community to advance new life saving radiopharmaceutical solutions. CNRI-H is a turnkey solution that integrates both funding and project execution in one award.

The focus of the program is Radiopharmaceutical Therapy optimization, Toxicology and Pre-clinical Evaluation research. The goal of the program is to accelerate the optimization of therapeutic isotopes production and  the  clinical translation of targeted radiopharmaceuticals for the benefit of Canadians whilst increasing the safety and efficacy of therapies that involve radiopharmaceuticals.

CNL will be working with the selected third-party proponents in Canada and internationally on projects to be delivered as contract research. CNL would be financially supporting these projects by contributing significantly to the project cost as a matching grant in-kind (cost sharing details are elaborated in section 2.1).

Annually, CNL will issue CNRI-H call for proposals (CFP), review the proposals received and select the proposals that fall within defined preselection criteria. CNL will then proceed to formalize agreements with the selected party (ies) to deliver the project(s). CNL does not intend to share in the ownership of R&D deliverables under the CNRI-H program. Project execution will begin in May 2024 and may continue for a maximum of 24 months.

For more information, or to submit your proposal, email

CNRI Program Timeline

January 29, 2024 / CNRI-H call for proposals open

March 11, 2024 / Deadline for proposal submission. 12 PM ET

March 25, 2024 / CNL reviews and selects proposals to proceed to negotiations.

May 31, 2024 / Successful agreements announced and work begins.

Focus Areas

A call for proposals (CFP) will be issued as part of the CNRI program. Included in each CFP will be a list of focus areas. The list of focus areas is as follows:

Potential Award Details

Annually, CNL will enter into a series of jointly funded R&D projects that will utilize S&T (Science and Technology) services from CNL to accelerate the discovery, development and approval of targeted radiopharmaceuticals for the benefit of Canadians. Projects must be within the CNRI program focus areas. Applicants are expected to, at a minimum, match the value contributed by CNL in monetary or in-kind contribution.

Icon CNL

Get in touch with us to learn more:

Send us your Feedback

Contact our Commercial Services team at